** Healthcare services co Healius HLS.AX announces high single-digit EBIT margin target for FY27, exceeding estimates of Citi and Jefferies

** Market might maintain healthy level of scepticism about this target given previous false starts and valuation that is still relatively high, Citi says

** Jefferies notes potential for significant EBIT uplift, but says it will update its forecasts in line with delivery of these targets

** Jefferies also sees green shoots in Australian healthcare services and hopes HLS can benefit from this

** Citi maintains its target price at A$1.05 and rating at "neutral"; Jefferies raises target price from A$1.45 to A$1.65, keep "hold" rating

** Stock up 5.8% YTD

(Reporting by Kumar Tanishk in Bengaluru)

((Tanishk.Kumar@thomsonreuters.com; X: @thatstanishk;))